| Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181) |
|---|
| 11/05/2008 | CN101297969A Combinations of the peroxisome proliferator-activated receptor (PPAR) activator fenofibrate with sterol absorption inhibitor ezetimibe for vascular indications |
| 11/05/2008 | CN101297807A The use of 5-HT4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions |
| 11/04/2008 | CA2443449C Pyrazole derivatives for treating hiv |
| 10/30/2008 | US20080269344 respiratory diseases such as asthma, chronic obstructive pulmonary disease, bronchitis; useful in the treatment of nervous system injury and premature labor; 1-{2-[N-2-(4-hydroxy-3-formylaminophenyl)-2-(RS) hydroxyethyl]aminoethyl}-4-[N-(2-phenyl-2-(RS)-hydroxyethyl)amino]phenyl; milveterol |
| 10/30/2008 | US20080269197 antipsychotic agents; phenylsulfonyl compounds; 7-Methoxy-8-(3-phenoxy-benzenesulfonyl)-2,3,4,5-tetrahydro-1H-3-benzazepine; schizophrenia |
| 10/30/2008 | US20080268033 Biologically active methylene blue derivatives |
| 10/29/2008 | CN101293867A Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 10/29/2008 | CN100429201C Heterocyclic compounds and methods of use thereof |
| 10/28/2008 | US7442705 HIV replication inhibiting pyrimidines and triazines |
| 10/28/2008 | CA2358632C Drug combinations comprising (e)-7-¬4-(4-fluorophenyl)-6-isopropyl-2-¬methyl(methylsulfonyl)amino|pyrimidin-5-yl|(3r,5s)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4 |
| 10/28/2008 | CA2342102C Tan-1057 derivatives |
| 10/23/2008 | US20080261960 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents |
| 10/22/2008 | EP1443945B1 Use of a mixture of sodium hyaluronate and chondroitin sulfate for the treatment of osteoarthritis or chondromalacia |
| 10/22/2008 | EP1311679B1 Method for inhibiting il-22 induced pap1 |
| 10/16/2008 | US20080255363 Novel Form of S-Omeprazole |
| 10/16/2008 | US20080255209 Combination of a NSAID and a PDE-4 inhibitor |
| 10/15/2008 | CN101284819A Fused pyridazine derivative compounds and drugs containing these compounds as the active ingredient |
| 10/14/2008 | US7435744 Brain disorders; central nervous system disorders; viricides |
| 10/08/2008 | CN100424079C Bis-sulfonamides |
| 10/07/2008 | US7432370 Mixing a racemic mixture of enantiomers of pyrrolo[2,3-d]pyrimidine compounds in a solvent, with a resolving compound having a defined stereospecificity, to form a solution and with resolving agent being capable of binding with enantiomers to form a precipitate collecting precipitate and purifying |
| 10/02/2008 | US20080242702 Paclitaxel enhancer compound |
| 10/01/2008 | CN101274928A 3-substituted-4-pyrimidone derivatives |
| 10/01/2008 | CN100422160C Novel morpholine derivatives, method for production thereof and pharmaceutical preparations containing said derivatives |
| 10/01/2008 | CN100421732C Plaster for the treatment of dysfunctions and disorders of nails |
| 09/30/2008 | US7429578 e.g. phenyl-3,4-dihydropyrrolo[4,3,2-de]isoquinolin-5-(1H)-one; anticarcinogenic agent; stroke, head trauma, and neurodegenerative disease; potentiating cytotoxicity of a DNA-damaging cytotoxic agent or ionizing radiation |
| 09/30/2008 | US7429389 inactivated or attenuated Mycoplasma bovis biotype and a carrier; vaccinating cows; no undesirable side effects and protect against M. bovis related disease, such as contagious mastitis, respiratory pneumonia, joint infections, keratoconjunctivitis and middle ear infections |
| 09/23/2008 | US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 09/23/2008 | US7427639 β2-adrenergic receptor agonists |
| 09/23/2008 | CA2432872C Pyrazole compounds useful as protein kinase inhibitors |
| 09/18/2008 | US20080226671 Deactivation or attenuation Mycoplasma vaccine for cattle; side effect reduction; respiratory system disorders ; mammary disorders; joint, eye, ear infections |
| 09/17/2008 | EP1409477B1 Piperidine derivatives as nmda receptor antagonists |
| 09/17/2008 | CN101265262A New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 09/17/2008 | CN100418967C Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 09/17/2008 | CN100418533C Pharmaceutical combinations of cox-2 inhibitors and opiates |
| 09/04/2008 | US20080214812 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition |
| 09/04/2008 | US20080214655 Paclitaxel or a paclitaxel analog and 2,5-Dimethoxythiobenzoic acid N-methylhydrazine; antitumor; nontoxic |
| 09/03/2008 | CN101255434A Vaccines |
| 09/03/2008 | CN101254302A Treatment of autoimmune diseases with antagonists which bind to b cell surface markers |
| 09/03/2008 | CN100415737C Indole derivatives useful for treatment of CNS disorders |
| 09/03/2008 | CN100415735C Amino alcohol derivatives |
| 09/03/2008 | CN100415188C Condom with erectogenic composition |
| 08/28/2008 | US20080206335 Inert non-pareil core, fluvoxamine layer over core, rate-controlling membrane coating; fluvoxamine released over a period of 12 hours or more; once-daily oral administration |
| 08/27/2008 | CN100413860C Piperidine derivative as NMDA receptor antagonist |
| 08/26/2008 | US7417034 Pharmaceutically active uridine esters |
| 08/26/2008 | US7416734 Vaccines for Mycoplasma bovis and methods of use |
| 08/26/2008 | CA2432129C Pyrazole compounds useful as protein kinase inhibitors |
| 08/26/2008 | CA2361614C Compositions for treating inflammatory response |
| 08/20/2008 | EP1958956A2 Peptidomimetic protease inhibitors |
| 08/20/2008 | EP1249233B1 Npyy5 antagonists |
| 08/20/2008 | CN101245058A Inhibitors of aspartyl protease |
| 08/19/2008 | CA2432799C Pyrazole compounds useful as protein kinase inhibitors |
| 08/13/2008 | EP1956004A1 Quinoline derivatives and their use as 5-HT6 ligands |
| 08/13/2008 | CN100410245C Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 08/12/2008 | US7411070 Form of S-omeprazole |
| 08/06/2008 | CN100408573C Pyrazole compounds useful as protein kinase inhibitors |
| 08/06/2008 | CN100408564C Pyrazole derivatives for treating HIV |
| 08/05/2008 | US7407974 e.g. 4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 2-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
| 08/05/2008 | US7407972 e.g. 4,5-Dihydro-pyrazole-1,5-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 5-[(3-fluoro-2'-methanesulfonyl-biphenyl-4-yl)-amide]; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
| 07/30/2008 | CN100406454C Pyrazole compounds useful as protein kinase inhibitors. |
| 07/30/2008 | CN100406437C Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these |
| 07/30/2008 | CN100406008C Pharmaceutical composition comprising lumiracoxib |
| 07/29/2008 | CA2432222C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2432132C Pyrazole compounds useful as protein kinase inhibitors |
| 07/23/2008 | EP1671949B1 Substituted Pyridinylamines |
| 07/16/2008 | EP1318835B1 Use of imidazoquinolinamines as adjuvants in dna vaccination |
| 07/16/2008 | EP1165551B1 C10 carbamoyloxy substituted taxanes as antitumor agents |
| 07/16/2008 | CN101219204A Combinations comprising a low molecular weight thrombin inhibitor and a prodrug of a low molecular weight thrombin inhibitor |
| 07/16/2008 | CN101219145A Quinazoline derivatives as VEGF inhibitors |
| 07/16/2008 | CN100402499C 2-iminopyrrolidine derivatives |
| 07/15/2008 | US7399472 Vaccines |
| 07/15/2008 | CA2362271C Essential fatty acids in the prevention of cardiovascular events |
| 07/09/2008 | EP1220842B1 Cyclic amine compound as ccr5 antagonist |
| 07/08/2008 | US7396847 Oxazolidinone and/or isoxazoline as antibacterial agents |
| 07/08/2008 | US7396826 prophylaxis/therapy of diabetes, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative and neuropathic diseases, neuropathic pain, polyneuropathy using e.g. Octadeca-6,9,12-trienoic acid 5' -(2,4-dioxo-3,4-dihydro-2H-pyrimidine-1-yl)-3',4 dihydroxy-tetrahydrofuran-2'-yl methyl ester |
| 07/08/2008 | CA2432131C Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2008 | CA2383164C Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system |
| 07/01/2008 | US7393846 phosphodiesterase type 4 inhibitors; N-(3,5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methanesulfonamido-dibenzo[b,d]furan-1-carboxamide; antiinflammatory agent, antiallergen; asthma or chronic obstructive pulmonary disease |
| 06/26/2008 | US20080153864 Spiroazabicyclic Heterocyclic Compounds |
| 06/25/2008 | CN100396680C Vla-4 inhibitors |
| 06/11/2008 | EP1497266B1 Quinoline derivatives and their use as 5-ht6 ligands |
| 06/10/2008 | US7384962 Heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 06/04/2008 | EP1927357A2 Low hygroscopic aripiprazole (crystal E) drug substance and processes for the preparation thereof |
| 06/04/2008 | EP1927356A1 Low hygroscopic aripiprazole (crystal D) drug substance and processes for the preparation thereof |
| 06/04/2008 | EP1927355A1 Low hygroscopic aripiprazole (crystal F) drug substance and processes for the preparation thereof |
| 06/03/2008 | CA2368186C Use of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 05/29/2008 | US20080124413 Novel composition containing extracts of butyrospermum parkii and the use of such a composition for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation hypersensitivity or pain |
| 05/28/2008 | EP1925308A1 Low hygroscopic aripiprazole (crystal G) drug substance and processes for the preparation thereof |
| 05/28/2008 | CN100390153C Intermediate for producing novel pyrazine derivatives |
| 05/21/2008 | CN101181236A Exendin agonist peptide formulations and administration method thereof |
| 05/20/2008 | CA2432223C Pyrazole compounds useful as protein kinase inhibitors |
| 05/13/2008 | US7371820 Nutraceuticals for the treatment, protection and restoration of connective tissues |
| 05/13/2008 | US7371744 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents |
| 05/13/2008 | CA2410234C 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl in pure crystalline form and process for synthesis |
| 05/08/2008 | US20080108619 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 05/08/2008 | US20080108591 2-amino-3,6-dihydro-4-dimethyl-amino-6-ethyl-1,3,5-triazine hydrochloride; advanced glycosylation end-products inhibitor;antidiabetic, insulin resistance, neurodegenerative disorders, renal complications, atherosclerosis, angiopathy |
| 05/07/2008 | EP1347981B1 Condensed purine derivatives as a 1 adenosine receptor antagonists |
| 05/06/2008 | US7368473 Paclitaxel enhancer compounds |
| 04/30/2008 | CN100384413C Combination of selected opioids with muscarine antagonists for treating urinary incontinence |
| 04/29/2008 | US7365205 Diamine derivatives |
| 04/24/2008 | US20080097361 Component for Forming a Seal Around an Opening in the Skin |